Stay updated on Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.

Latest updates to the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page
- Check6 days agoChange DetectedThe history now shows that recruitment has ended for the study ('No longer looking for participants'). A new release note 'Revision: v3.6.0' was added and the previous release 'Revision: v3.5.5' was removed.SummaryDifference0.4%

- Check13 days agoChange DetectedThe history page now shows a new site revision, v3.5.5, replacing the previous v3.5.4. This indicates an underlying platform update or deployment behind the page, not changes to trial data.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe revision label on the history page updated from v3.5.3 to v3.5.4, indicating a new site release was deployed behind the page. This reflects a backend update rather than a change to trial information.SummaryDifference0.1%

- Check49 days agoChange DetectedNew entry added: revision v3.5.3. The corresponding deletion shows v3.5.2 is superseded, reflecting a page version update.SummaryDifference0.1%

- Check56 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.0 to v3.5.2, with no other study-record changes shown.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision v3.5.0 was added to the record history and revision v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on Peak VO2 in HFrEF Clinical Trial page.